Treatment patterns in pediatric patients with multiple sclerosis in Germany—a nationwide claim-based analysis

BACKGROUND: The manifestation of multiple sclerosis (MS) in childhood and adolescence occurs in 3%−5% of all MS cases. However, the immunomodulatory and symptomatic treatment options in this population group are still limited. OBJECTIVE: We aimed to elucidate the prescription frequency of medication...

Descripción completa

Detalles Bibliográficos
Autores principales: Frahm, Niklas, Peters, Melanie, Bätzing, Jörg, Ellenberger, David, Akmatov, Manas K., Haas, Judith, Rommer, Paulus S., Stahmann, Alexander, Zettl, Uwe K., Holstiege, Jakob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504210/
https://www.ncbi.nlm.nih.gov/pubmed/34646362
http://dx.doi.org/10.1177/17562864211048336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504210/
https://www.ncbi.nlm.nih.gov/pubmed/34646362
http://dx.doi.org/10.1177/17562864211048336

Ejemplares similares